We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Blood Test Biomarkers Diagnose Autism Accurately

By LabMedica International staff writers
Posted on 08 Mar 2018
Autism spectrum disorder (ASD) is a condition that impacts cognition, behavior and social interaction, causing a wide spectrum of other disabilities, such as speech disturbances, repetitive and/or compulsive behaviors, hyperactivity, anxiety and difficulty to adapt to new environments.

Given its developmental nature, ASD may have an early onset, but it typically takes a while for the first symptoms to appear. More...
As such, early diagnosis is not usually possible. Therefore, a chemistry-based diagnosis test for the early detection of ASD may be crucial, enabling children to receive the care that they need much earlier on, but until now, no such test was available.

An international team of scientists led by those at the University of Warwick (Coventry, UK) recruited 38 children with ASD (29 male, nine female; age 7.6 ± 2.0 years) and 31 age-matched healthy controls (23 males, eight females; 8.6 ± 2.0 years). Blood was withdrawn in the morning from fasting children. Spot urine samples were the first ones in the morning. Blood samples were collected using ethylenediaminetetra-acetic acid as anticoagulant. Plasma and blood cells were separated immediately by centrifugation (2000g, 10 minutes) and plasma samples stored at − 80 °C until analysis.

The content of glycated, oxidized, and nitrated adduct residues in plasma protein was quantified in exhaustive enzymatic digests by stable isotopic dilution analysis liquid chromatography-tandem mass spectrometry (LC-MS/MS, Acquity UPLC system with a Xevo-TQS tandem mass spectrometer; Waters, Manchester, UK; www.waters.com), with correction for autohydrolysis of hydrolytic enzymes. Machine learning methods were then employed to explore and optimize combinations of analyte data for ASD diagnosis.

The team found that children with ASD had increased advanced glycation end products (AGEs), Nε-carboxymethyl-lysine (CML) and Nω-carboxymethylarginine (CMA), and increased oxidation damage marker, dityrosine (DT), in plasma protein, with respect to healthy controls. Theye also found that children with ASD had increased CMA free adduct in plasma ultrafiltrate and increased urinary excretion of oxidation free adducts, alpha-aminoadipic semialdehyde and glutamic semialdehyde. The children with ASD had decreased renal clearance of arginine and CMA with respect to healthy controls. The sensitivity, specificity and receiver-operating characteristic area-under-the-curve were 92%, 84%, and 0.94, respectively. The study was published on February 19, 2018, in the journal Molecular Autism.


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Integrated Biochemical & Immunological System
Biolumi CX8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.